Dr. Bleeker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1309 W 17th St
Ste 101
Sioux Falls, SD 57104Phone+1 605-328-8000Fax+1 605-328-8001
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2009 - 2013
University of Virginia Medical CenterResidency, Internal Medicine, 2005 - 2009
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 2005
Certifications & Licensure
IA State Medical License 2024 - 2026
MN State Medical License 2009 - 2025
SD State Medical License Active through 2025
VA State Medical License 2005 - 2010- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 1235 citationsSafety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-05...Charles S. Fuchs, Toshihiko Doi, Raymond Jang, Kei Muro, Taroh Satoh
JAMA Oncology. 2018-05-10 - 20 citationsCulture media composition influences patient-derived organoid ability to predict therapeutic responses in gastrointestinal cancers.Tara L Hogenson, Hao Xie, William J Phillips, Merih D Toruner, Jenny J Li
JCI Insight. 2022-11-22 - 424 citationsPrevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline updateCharles L. Loprinzi, Christina Lacchetti, Jonathan Bleeker, Guido Cavaletti, Cynthia Chauhan
Journal of Clinical Oncology. 2020-07-14
Journal Articles
- Scleroderma‐like Skin Changes Induced by Checkpoint Inhibitor TherapyAli D Jassim, Jonathan S Bleeker, B Joel Tjarks, Amy M Kerkvliet, Journal of Cutaneous Pathology
Press Mentions
Sanford Health Celebrates People Behind Clinical TrialsMay 20th, 2021
Sanford Studying Immunotherapy Drug for Esophageal CancerJanuary 31st, 2017- Lung Cancer: Chances, Symptoms and PreventionDecember 8th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
